CurrentEndo
Get Weekly

Topic · page 24 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 921–960 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. J Clin Endocrinol Metab

    Insulin Receptor Family Autoantibodies in Patients with Type B Insulin Resistance

    Cross-sectional study

  2. Diabetes Res Clin Pract

    Risk of coronary artery disease in intermediate hyperglycemia and type 2 diabetes defined by 1-hour post-load glucose levels according to the new IDF criteria

    Cross-sectional study

  3. Diabetes Res Clin Pract

    Identification of oral microbial biomarkers for prediabetes in young adults: A two-stage population-based study

    Cross-sectional study

  4. Diabetes Care

    Associations of Moderate-to-Vigorous Physical Activity Timing With Type 2 Diabetes Incidence in UK Biobank and Prevalent Glycemic Measures in NHANES

    Cross-sectional study

  5. Int J Obes (Lond)

    Metabolic syndrome in Australia: nationwide survey results by remoteness and Indigenous status, 2012–2019

    Cross-sectional study

  6. Diabetes Res Clin Pract

    Association between the insulin resistance indices and incident type 2 diabetes across different body mass index states: a cohort study and external validation from two East Asian populations

    Cohort study

  7. Cardiovasc Diabetol

    Cardiac vagal activity is associated with insulin metabolism in heart failure: Results from the Myovasc study

    Cohort study

  8. Diabetes Obes Metab

    Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

    Meta-analysis

  9. Diabetes Obes Metab

    Comparison of cardiovascular outcomes between once‐weekly semaglutide and dulaglutide in adults with type 2 diabetes and established atherosclerotic cardiovascular disease in the United States

    Cohort study

  10. Diabetes Obes Metab

    GLP1 ‐ 1RAs improve walking distance and reduce amputation in people with type 2 diabetes and peripheral artery disease: A systematic review and meta‐analysis of randomised controlled trials and cohort studies

    Meta-analysis

  11. Diabetes Obes Metab

    Long‐term effects of a multidomain intervention on cognitive function and metabolic control in older adults with type 2 diabetes and mild cognitive impairment: A 42‐month follow‐up of the J‐ MIND ‐Diabetes study

    Randomized controlled trial

  12. Diabetes Obes Metab

    Pharmacokinetic properties of insulin GZR4 after subcutaneous administration in the thigh, abdomen, or upper arm in healthy participants

    Randomized controlled trial

  13. Diabetes Res Clin Pract

    Glucagon-like peptide-1 receptor agonists and risk of osteoarthritis among individuals with type 2 diabetes: A population-based cohort study

    Cohort study

  14. Diabetes Care

    Association Between GLP-1 Receptor Agonists and Ischemic Optic Neuropathy: A Meta-analysis

    Meta-analysis

  15. Diabetologia

    Dynamic changes in circulating microRNAs during oral glucose tolerance testing support their potential as diagnostic and monitoring biomarkers in cystic fibrosis-related diabetes

    Cross-sectional study

  16. Diabetes Obes Metab

    Once‐weekly insulin icodec versus once‐daily insulin degludec for type 2 diabetes in China: A cost‐utility and budget impact analysis

    Cohort study

  17. Diabet Med

    Burden of type 2 diabetes in Asia‐Pacific regions, 1990–2021: GBD 2021 analysis with forecast to 2050

    Secondary analysis

  18. Diabet Med

    Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II

    Cohort study

  19. Diabetes Obes Metab

    Associations between anthropometric measures of obesity and prediabetes risk: A dose–response meta‐analysis of cohort studies

    Meta-analysis

  20. Diabetes Obes Metab

    Dual action of imeglimin on insulin secretion and sensitivity in type 2 diabetes

    Research article

  21. Diabetes Obes Metab

    Effects of age and disease duration on the glycaemic outcomes and safety of insulin glargine 300 U/ mL in people with type 2 diabetes in China: A post‐hoc analysis of the INITIATION study

    Secondary analysis

  22. Diabetes Obes Metab

    Increasing cardiovascular mortality in young adults with diabetes mellitus as a contributing cause in the United States

    Cross-sectional study

  23. Diabetes Obes Metab

    Oral semaglutide and survival in heart failure with preserved ejection fraction and type 2 diabetes

    Cohort study

  24. Diabetes Res Clin Pract

    The effects of e-Health and artificial intelligence literacy levels on disease self-management in patients with diabetes

    Cross-sectional study

  25. Diabetes Obes Metab

    The importance of treatment sequencing with SGLT2 inhibitors and GLP ‐1 receptor agonists combination for kidney function preservation in type 2 diabetes

    Cohort study

  26. Diabetes Obes Metab

    Age disparities in SGLT2 inhibitor prescription among people with type 2 diabetes: The role of frailty and sex

    Cross-sectional study

  27. Diabetes Obes Metab

    Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes

    Cohort study

  28. J Clin Endocrinol Metab

    GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization

    Cohort study

  29. JAMA Netw Open

    Glucagon-Like Peptide-1 Receptor Agonists and Prior Major Adverse Limb Events in Patients With Diabetes

    Cohort study

  30. JAMA Netw Open

    Interactive Virtual Assistant for Health Promotion Among Older Adults With Type 2 Diabetes: The IVAM-ED Randomized Clinical Trial

    Randomized controlled trial

  31. JAMA Netw Open

    Metformin, Maternal Glycemic Control, and Neonatal Hypoglycemia After Antenatal Steroids: A Randomized Clinical Trial

    Randomized controlled trial

  32. JAMA Netw Open

    Volunteering and Metabolic Syndrome and Diabetes in Black Adolescents From Low-Income Families

    Cohort study

  33. JAMA Intern Med

    Liraglutide in Acute Minor Ischemic Stroke or High-Risk Transient Ischemic Attack With Type 2 Diabetes: The LAMP Randomized Clinical Trial

    Randomized controlled trial

  34. Diabetes Care

    Metabolic Factors Modulating the Connection Between Diabetes and Pulmonary Alterations

    Cross-sectional study

  35. BMJ Open Diabetes Res Care

    Identification and characterization of novel PAX4 variants in patients with suspected MODY9

    Mechanistic study

  36. Diabetes Res Clin Pract

    Simultaneous assessment of one-hour plasma glucose levels and age as a potential predictor of glucose intolerance development in individuals with normal glucose tolerance

    Cohort study

  37. Cardiovasc Diabetol

    Indications, prognosis, and complications of de Novo implantable cardioverter defibrillators in patients with and without type 2 diabetes: a nationwide registry-based cohort study

    Cohort study

  38. BMJ Open Diabetes Res Care

    Trends in delaying and forgoing medical care due to cost and the association with insurance status among US adults with diabetes, 2009–2023

    Cross-sectional study

  39. Cardiovasc Diabetol

    Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes

    Randomized controlled trial

  40. Ann Intern Med

    Effectiveness and Safety of Statins in Type 2 Diabetes According to Baseline Cardiovascular Risk : A Target Trial Emulation Study

    Cohort study

All 4,758 Briefs in ExploreShowing Briefs 921–960 of 4,758, newest first